CD46 and cancer: We thus hypothesize that CD46/TREM1 may contribute to the inflammation-cancer transformation in OSCC by activating the PI3K-AKT-mTOR pathway and subsequently inhibiting autophagy, as indicated by downregulated LC3B/ATG5.